26Feb 24Ayobami gives Plenary at the 2024 AAAAI: “Pharmacoequity in Eligibility & Access to Biologics in Patients with Asthma”.Read more...24Feb 24Tanawin showcases Drug U.S.E Lab’s research on the real-world effectiveness of the anti-TSLP agent, tezepelumab, in severe asthma.Read more...19Dec 23Tanawin received a travel scholarship award to attend the 2024 AAAAIRead more...24May 23The Drug USE Lab at ATS 2023Read more...12May 23Tanawin presents research on lung function trajectoriesRead more...
26Feb 24Ayobami gives Plenary at the 2024 AAAAI: “Pharmacoequity in Eligibility & Access to Biologics in Patients with Asthma”.Read more...
24Feb 24Tanawin showcases Drug U.S.E Lab’s research on the real-world effectiveness of the anti-TSLP agent, tezepelumab, in severe asthma.Read more...
